Synergism with germ line transcription factor Oct-4: Viral oncoproteins share the ability to mimic a stem cell-specific activity

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 2635-2643

  Brehm, A ^a,c   Ohbo, K ^a   Zwerschke, W ^b   Botquin, V ^a   Jansen Durr P ^b,d   Scholer H R ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c WELLCOME CRC INSTITUTE   (United Kingdom)

^d Inst fur Biomed Alternsforschung   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BINDING SITE; CELL SPECIFICITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION;

ADENOVIRIDAE; ANIMALIA; HUMAN PAPILLOMAVIRUS;

EID: 0032940189     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.4.2635     Document Type: Article

References (51)

1. Ambrosetti, D. C., C. Basilico, and L. Dailey. 1997. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 17:6321-6329.
2. Antinore, M. J., M. J. Birrer, D. Patel, L. Nader, and D. J. McCance. 1996. The human papillomavirus type 16 E7 gene product interacts with and transactivates the AP1 family of transcription factors. EMBO J. 15:1950-1960.
3. Arany, Z., D. Newsome, E. Oldread, D. M. Livingston, and R. Eckner. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81-84.
4. Babb, R., M. A. Cleary, and W. Herr. 1997. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol. Cell. Biol. 17:7295-7305.
5. Bannister, A. J., and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
6. Botquin, V., H. Hess, K. Anastassiadis, M. Gross, G. Fuhrmann, G. Vriend, and H. R. Schöler. 1998. Antagonistic osteopontin regulation by Oct-4 and Sox-2 in cells of the mouse preimplantation embryo. Genes Dev. 12:2073-2090.
7. Brehm, A., K. Ohbo, and H. R. Schöler. 1997. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol. Cell. Biol. 17:154-162.
8. Brehm, A., C. E. Ovitt, and H. R. Schöler. 1998. Oct-4: more than just a POUerful marker of the mammalian germline? APMIS 106:114-124.
9. Brinster, R. L. 1974. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 140:1049-1056.
10. Chiang, C. M., and R. G. Roeder. 1995. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267: 531-536.
11. Condorelli, G., and A. Giordano. 1997. Synergistic role of E1A-binding proteins and tissue-specific transcription factors in differentiation. J. Cell. Biochem. 67:423-431.
12. Davies, R., R. Hicks, T. Crook, J. Morris, and K. Vousden. 1993. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67:2521-2528.
13. Eckner, R. 1996. p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem. 377:685-688.
14. Eckner, R., J. W. Ludlow, N. L. Lill, E. Oldread, Z. Arany, N. Modjtahedi, J. A. DeCaprio, D. M. Livingston, and J. A. Morgan. 1996. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16:3454-3464.
15. Garriga, J., A. Limon, X. Mayol, S. G. Rane, J. H. Albrecht, E. P. Reddy, V. Andres, and X. Grana. 1998. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem. J. 333:645-654.
16. Geisberg, J. V., J. L. Chen, and R. P. Ricciardi. 1995. Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex. Mol. Cell. Biol. 15:6283-6290.
17. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
18. Herr, W., and M. A. Cleary. 1995. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9:1679-1693.
19. Hess, H., and H. R. Schöler. Unpublished results.
20. Ikeda, M. A., and J. R. Nevins. 1993. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol. Cell. Biol. 13:7029-7035.
21. Imperiale, M. J., H. T. Kao, L. T. Feldman, J. R. Nevins, and S. Strickland. 1984. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol. Cell. Biol. 4:867-874.
22. Jansen-Duerr, P. 1996. How viral oncogenes make the cell cycle. Trends Genet. 12:270-275.
23. Johnston, S. D., X. M. Yu, and J. E. Mertz. 1996. The major transcriptional transactivation domain of simian virus 40 large T antigen associates nonconcurrently with multiple components of the transcriptional preinitiation complex. J. Virol. 70:1191-1202.
24. Kawasaki, H., R. Eckner, T. P. Yao, K. Taira, R. Chiu, D. M. Livingston, and K. K. Yokoyama. 1998. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393:284-289.
25. Lee, J. O., A. A. Russo, and N. P. Pavletich. 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859-865.
26. Lefstin, J. A., and K. R. Yamamoto. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392:885-888.
27. Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. L. Harter, and R. H. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85-88.
28. Mal, A., R. Y. C. Poon, P. H. Howe, H. Toyoshima, T. Hunter, and M. L. Harter. 1996. Inactivation of p27(Kip1) by the viral E1A oncoprotein in TGF beta-treated cells. Nature 380:262-265.
29. Massimi, P., D. Pim, A. Storey, and L. Banks. 1996. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12:2325-2330.
30. Matthias, P. 1998. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what? Semin. Immunol. 10:155-163.
31. Minucci, S., V. Botquin, I. Y. Young, A. Dey, I. Sylvester, D. J. Zand, K. Ohbo, K. Ozato, and H. Schöler. 1996. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J. 15:888-899.
32. Nichols, J., B. Zevnik, K. Anastassiadis, H. Niwa, D. Klewe-Nebenius, I. Chambers, H. R. Schöler, and A. Smith. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell 95:379-391.
33. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
34. Okamoto, K., H. Okazawa, A. Okuda, M. Sakai, M. Muramatsu, and H. Hamada. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472.
35. Ovitt, C. E., and H. R. Schöler. 1998. Oct-4 and the molecular biology of preimplantation development. Mol. Hum. Reprod. 4: 1021-1031.
36. Papaioannou, V. E., M. W. McBurney, R. L. Gardner, and M. J. Evans. 1975. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 258:70-73.
37. Pesce, M., M. Gross, and H. R. Schöler. 1998. In line with our ancestors: Oct-4 and the mammalian germ. BioEssays 20:722-732.
38. Schöler, H. R. 1991. Octamania: the POU factors in murine development. Trends Genet. 7:323-329.
39. Schöler, H. R., R. Balling, A. K. Hatzopoulos, N. Suzuki, and P. Gruss. 1989. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J. 8:2551-2557.
40. Schöler, H. R., T. Ciesiolka, and P. Gruss. 1991. A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells. Cell 66:291-304.
41. Schöler, H. R., G. R. Dressler, R. Balling, H. Rohdewohld, and P. Gruss. 1990. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9:2185-2195.
42. Schöler, H. R., A. K. Hatzopoulos, R. Balling, N. Suzuki, and P. Gruss. 1989. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 8:2543-2550.
43. Slack, R. S., P. A. Hamel, T. S. Bladon, R. M. Gill, and M. W. McBurney. 1993. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene 8:1585-1591.
44. Svensson, C., M. Bondesson, E. Nyberg, S. Linder, N. Jones, and G. Akusjarvi. 1991. Independent transformation activity of adenovirus-5 E1A-conserved regions 1 or 2 mutants. Virology 182:553-561.
45. Sylvester, I., and H. R. Schöler. 1994. Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res. 22:901-911.
46. Trouche, D., and T. Kouzarides. 1996. E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc. Natl. Acad. Sci. USA 20:1439-1442.
47. Vigano, M. A., and L. M. Staudt. 1996. Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1. Nucleic Acids Res. 24:2112-2118.
48. Vousden, K. H. 1995. Regulation of the cell cycle by viral oncoproteins. Semin. Cancer Biol. 6:109-116.
49. Yuan, H., N. Corbi, C. Basilico, and L. Dailey. 1995. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:2635-2645.
50. Zerfass-Thome, K., W. Zwerschke, J. Botz, and P. Jansen-Durr. 1996. Inactivation of the cdk inhibitor p27/KIP1 by human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330.
51. Zwerschke, W., S. Joswig, and D. P. Jansen. 1996. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene 12:213-220.